GLG News by Silicone Hydrogel and Bausch and Lomb Contact Lens Prescribers: Ophthalmologists and Optometrists (US)

A recent study showed that children aged 8-12 were just as successful as teenagers aged 13-17 in the areas of physiological adjustment and contact lens care.  I find this is true in my practice as well.  Not only can prescribing to this younger demographic change a child's life, it can...

The recent purchase by Bausch & Lomb of Eyeonics shows a good move to capture the growing presbyopic correction market. The company has also sent Ronald L. Zarrella to become chairman emeritus. One of the best moves I have heard since the whole Renu problem.

With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.

Macular degeneration is a condition where the central part of the retina is lost. This item places an image on the retina that is so big, it allows the use of the remaining, useful retina. Sounds great! It may be, however, as with many low vision devices, there are some potential pitfalls.

"Customized" intraocular lenses are gradually making their way into the mainstream of ocular surgery. First there were multifocal and accommodating IOLs. Now there are toric IOLs. And the future is upon us for more sophisticated designs such as the telescopic IOL.  As with any new technology,...

The potential market for a newer and better optical solution to the problem of presbyopia is limitless.  Any optical system which functions with fewer "compromises" than those we have now will be a welcome addition even if its application is limited to just contact lenses alone. Broader applications...

The article points out that a small percentage of contact lenses and laser vision correction procedures, and cataract procedures deal with presbyopia. The field is wide open for improvement and exploitation. Numerous companies are looking for the "next best" idea.

This survey gives strong evidence to support issues that Eye Care Professionals deal with every day.  Most Americans (73%) believe that vision correction would help their ability to drive at night, and yet only 27% of those drivers have sought help from an Eye Doctor.  Why is there a...

The market for eye drops for the treatment of open angle glaucoma is huge. Profit potential for pharmaceutical companies, however, is limited by the time period that they are afforded patent protection. Combigan, the just approved brimonidine/timolol combination therapy, affords Allergan new patent...

Even though Bausch & Lomb appears to be getting back on its feet in the contact lens and solution market, their lawsuit woes continue to pile up.  At 573 and counting, these lawsuits are expected to cost them over $1 billion.